Jay Haynes

Running BackRB
Questionable
Injury Quadriceps
Est. Return 11/1/2025
2025 Fantasy Outlook
There was no outlook written for Jay Haynes in 2025. Check out the latest news below for more on his current fantasy value.
Remaining out against SMU
Quadriceps
October 16, 2025
Haynes (quadriceps) has been ruled out for Saturday's game against SMU.
ANALYSIS
Haynes will remain out for the Tigers during this weekend's matchup with the Mustangs. The 5-foot-11 redshirt sophomore, who suffered an offseason quad injury, has yet to suit up this season.
Read More News
College Football Stats
Loading CFB Stats...
2025 CFB Game Log
2024
2023
2024 CFB Game Log
Calculate Stats Over Time
Just click on any two dates.
Scoring
FanDuel
DraftKings
Head2Head
Loading Game Log...
2023 CFB Game Log
Calculate Stats Over Time
Just click on any two dates.
Scoring
FanDuel
DraftKings
Head2Head
Loading Game Log...
Tigers Depth Chart
Our full team depth charts are reserved for RotoWire subscribers.
Subscribe Now
Recent RotoWire Articles Featuring Jay Haynes See More
Recent RotoWire Articles Featuring Jay Haynes See More
More Fantasy News
Out at Boston College
Quadriceps
October 9, 2025
Haynes (quadriceps) is out for Saturday's game at Boston College, per the ACC availability report.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Out for Week 6
Quadriceps
October 2, 2025
Haynes (quadriceps) won't play in Week 6 against UNC.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Ruled out again
Quadriceps
September 18, 2025
Haynes (quadriceps) has been ruled out of Saturday's game versus Syracuse.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
'Progressing' with quad injury
Quadriceps
September 18, 2025
Haynes (quadriceps) is progressing but isn't yet at 100 percent, per On3.com.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Out again Saturday
Knee
September 11, 2025
Haynes (knee) won't play Saturday versus Georgia Tech, Jon Blau of The Charleston Post and Courier reports.
ANALYSIS
Subscribe now to instantly reveal our take on this news.